TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Study of Subretinally Injected SAR439483 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
Condition:   Leber's Congenital Amaurosis Interventions:   Drug: SAR439483;   Drug: SAR439483 Diluent Solution;   Drug: Prednisone;   Drug: Triamcinalone Acetonide;   Drug: 1% Prednisolone;   Drug: Trimethoprim/polymyxin B Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Study of Subretinally Injected SAR439483 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
Condition:   Leber's Congenital Amaurosis Interventions:   Drug: SAR439483;   Drug: SAR439483 Diluent Solution;   Drug: Prednisone;   Drug: Triamcinalone Acetonide;   Drug: 1% Prednisolone;   Drug: Trimethoprim/polymyxin B Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

TEMPO Study: Trimethoprim-Sulfamethoxazole in Granulomatosis With Polyangiitis
Conditions:   Granulomatosis With Polyangiitis;   Wegener Granulomatosis Intervention:   Drug: Trimethoprim Sulfamethoxazole Sponsor:   University of Pennsylvania Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

Study of Subretinally Injected SAR439483 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
Condition:   Leber's Congenital Amaurosis Interventions:   Drug: SAR439483;   Drug: SAR439483 Diluent Solution;   Drug: Prednisone;   Drug: Triamcinalone Acetonide;   Drug: 1% Prednisolone;   Drug: Trimethoprim/polymyxin B Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2019 Category: Research Source Type: clinical trials

The Effect of SLC19A3 Inhibition on the Pharmacokinetics of Thiamine
Conditions:   Vitamin B1 Deficiency;   Thiamine Deficiency Interventions:   Drug: Trimethoprim;   Drug: Metformin;   Dietary Supplement: Vitamin B1 Sponsors:   University of California, San Francisco;   Tufts University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of California, Davis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2018 Category: Research Source Type: clinical trials